LYN and head and neck squamous cell carcinoma: Additionally, in order to reduce the immunosuppressive microenvironment of HNSCC, Mao and colleagues focused on phosphorylation levels of SRC and LYN kinases in a HNSCC mouse model treated with Dasatinib.